Assyro AI
US FDAUnited StatesCRLComplete Response Letter

Complete Response Letter NDA 505b1 219357 (Dec 23, 2024)

Issued December 23, 2024

Issued

December 23, 2024

Application

NDA 505b1 • 219357

Review center

CDER

Stage

Final Decision

Letter type

Complete Response Letter

Response due December 23, 2025Requires resubmission addressing deficiencies.

Document viewer

Read the FDA letter and send context to the co-pilot at any time.

Loading PDF…